Acquired apparent mineralocorticoid excess induced by compound glycyrrhizin tablets: A case report and literature review.
A 57-year-old male developed severe hypertension and hypokalemia after 30 days of treatment with compound glycyrrhizin tablets.
Clinical pearl
Clinicians should consider acquired apparent mineralocorticoid excess in patients presenting with hypertension and hypokalemia, particularly those using glycyrrhizin-containing products.